Antibodies to citrullinated peptides in tuberculosis

Clinical Rheumatology

Volumn 32, Issue 5, 2013, Pages 685-687

  Lima, I ^a   Oliveira, R C ^b   Atta, A ^b   Marchi, S ^c   Barbosa, L ^c   Reis, E ^c   Reis, M G ^c   Santiago, M B ^a,d  

^a ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Serviços Especializados em Reumatologia da Bahia ^*  (Brazil)

Author keywords

ACPA; Anti CCP; Anti MCV; Rheumatoid arthritis; Rheumatoid factor; Tuberculosis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; VIMENTIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PREVALENCE; RHEUMATOID FACTOR; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY; VIMENTIN;

EID: 84878692330     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2173-y     Document Type: Article

References (17)

1. Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ (1994) The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 33(8):735-739
2. Marques Neto J, Gonçalves E, Langen L, Cunha M, Radominski S, Oliveira S et al (1993) Estudo multicêntrico da prevalência da artrite reumatóide do adulto em amostras da população brasileira. Rev Bras Reumatol 33:169-173
3. Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM et al (2004) Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 31(3):594-597
4. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569-2581
5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315-324
6. Mota LM, Laurindo IM, Santos Neto LL (2010) Early rheumatoid arthritis: concepts. Rev Assoc Med Bras 56(2):227-229, Mar
7. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS et al (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2(3):236-243
8. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43(1):155-163
9. Whiting PF, Smidt N, Sterne JA, Harbord R, Burton A, Burke M et al (2010) Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med 152(7):456-464, Apr 6
10. Elkayam O, Segal R, Lidgi M, Caspi D (2006) Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 65(8):1110-1112
11. Elkayam O, Segal R, Bendayan D, Van UR, Onnekink C, Pruijn GJ (2010) The anti-cyclic citrullinated peptide response in tuberculosis patients is not citrulline-dependent and sensitive to treatment. Arthritis Res Ther 12(1):R12
12. Kakumanu P, Yamagata H, Sobel ES, Reeves WH, Chan EK, Satoh M (2008) Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum 58(6):1576-1581
13. Mori S, Naito H, Ohtani S, Yamanaka T, Sugimoto M (2009) Diagnostic utility of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis in patients with active lung tuberculosis. Clin Rheumatol 28(3):277-283
14. Silva A, Matos A, Lima A, Lima E, Gaspar A, Braga J et al (2006) Valor diagnóstico do anticorpo antipeptídeo citrulinado cíclico na artrite reumatóide. Rev Bras Reumatol 46:174-180
15. Nienhuis RL, Mandema E (1964) A new serum factor in patients with rheumatoid arthritis; the antiperinuclear factor. Ann Rheum Dis 23:302-305
16. Santiago M, Baron M, Miyachi K, Fritzler MJ, Bu-Hakima M, Leclercq S et al (2008) A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clin Rheumatol 27(1):77-83
17. Lima I, Santiago M (2010) Antibodies against cyclic citrullinated peptides in infectious diseases - a systematic review. Clin Rheumatol 29(12):1345-1351